RABL2A

Across TCGA pan-cancer cohorts, RABL2A mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RABL2A data layer compared with 24 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RABL2A mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated RABL2A expression acts as an unfavorable survival marker.

UCEC and GBM are the cancer types where RABL2A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	0.286	0.700	.038	8	view →
GBM	DFS	Quartile	All	0.489	0.813	.043	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RABL2A–UCEC (DFS)

Open the UCEC breakdown →